These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4184933)

  • 1. [Change in the physico-chemical properties of antitoxic tetanus sera during preservation].
    Smakotina ZV
    Lab Delo; 1969; 4():245. PubMed ID: 4184933
    [No Abstract]   [Full Text] [Related]  

  • 2. [On duration of protection with dry immune homologous antitetanus plasma].
    Malyĭ GP; Tomenko EK
    Zh Mikrobiol Epidemiol Immunobiol; 1969; 46(6):123-6. PubMed ID: 5346263
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of DEAE-Sephadex A-50 for additional purification of antitoxic sera.
    Hristova G
    Prog Immunobiol Stand; 1970; 4():99-103. PubMed ID: 4098283
    [No Abstract]   [Full Text] [Related]  

  • 4. The isolation and study of pure antitoxic antibodies by the immunosorption method.
    Dalin MV; Kotova TS; Mertsalova NU
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):120-6. PubMed ID: 4736206
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of boric acid, freezing and lyophilization on the immunological and physicochemical properties of antirhesus sera].
    Klimova KN; Mineeva NV; Priezzheva LS
    Probl Gematol Pereliv Krovi; 1982 Jun; 27(6):59-60. PubMed ID: 6810334
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on tetanus antitoxins. II. Demonstration of at least four antitoxins of different specificity in antitoxic sera.
    Nagel J; Cohen H
    J Immunol; 1973 May; 110(5):1388-95. PubMed ID: 4633299
    [No Abstract]   [Full Text] [Related]  

  • 7. [Admixtures present in antitoxic horse sera and pepsin preparations].
    Trubitsina VI; Urykova VA; Chernobel' TP; Noskova VV; Panina NP
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Apr; (4):95-101. PubMed ID: 87071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A gel filtration study of the fractional composition of tetanus antitoxic sera].
    Runova VF; Kargina TM; Gavrilenkova VIu; Selezneva VP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):46-8. PubMed ID: 1887709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood and plasma preservatives as carriers of homologous tetanus antitoxin].
    Eckmann L
    Bibl Haematol; 1967; 27():268-9. PubMed ID: 5595092
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the antibody composition and neutralizing activity of tetanus antitoxin sera from various species of animals in relation to the antigenic substructure of the tetanus toxin molecule.
    Matsuda M; Makinaga G; Hirai T
    Biken J; 1983 Dec; 26(4):133-43. PubMed ID: 6204634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetanus toxoid boosters and human immune globulin for tetanus prophylaxis.
    Giliberty RP
    N Y State J Med; 1972 May; 72(10):1131-5. PubMed ID: 4503214
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of antitoxin titers and of antiserum antibodies after adminstration of tetanus antiserum in humans].
    Lo Sardo S; Catania S; Collarile P
    G Mal Infett Parassit; 1966 Oct; 18(10):673-5. PubMed ID: 5997198
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparation of active insoluble pepsin.
    Rao SS; Patki VM; Kulkarni AD
    Indian J Biochem; 1970 Sep; 7(3):210-1. PubMed ID: 4252584
    [No Abstract]   [Full Text] [Related]  

  • 14. The isolation and properties of the proteins associated with tetanus antitoxic activity in equine plasma.
    SMITH EL; GERLOUGH TD
    J Biol Chem; 1947 Mar; 167(3):679-87. PubMed ID: 20287898
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of low temperature preservation on several properties of antitoxic tetanus antiserum].
    Tsutsaeva AA; Markova VM; Medvedeva GG; Mikulinskiĭ IuE; Markova LA
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Jul; (7):71-5. PubMed ID: 899455
    [No Abstract]   [Full Text] [Related]  

  • 16. An attempt at using a monospecific tetanus antitoxin as a national reference preparation for flocculation tests.
    Vrancheva S; Valchev V; Gakev V; Bachev S
    Prog Immunobiol Stand; 1967; 3():341-5. PubMed ID: 4985513
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of tetanus. Experimental trial in guinea pigs with serum, toxoid and serotoxoid].
    Corrêa A; Tavares J
    Rev Inst Med Trop Sao Paulo; 1972; 14(4):246-8. PubMed ID: 5084219
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on tetanus antitoxin. I. Isolation of two neutralizing antibodies from tetanus antitoxin.
    Cohen H; Nagel J; van der Veer M; Peetoom F
    J Immunol; 1970 Jun; 104(6):1417-23. PubMed ID: 4192575
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunochemical activity of different isoelectric zones of diphtheria and tetanus antitoxins in immune sera].
    Kiriukhin IF; Kiriukhina DN
    Vopr Med Khim; 1973; 19(6):600-3. PubMed ID: 4212671
    [No Abstract]   [Full Text] [Related]  

  • 20. Properties of purified tetanus toxin and toxoid.
    Raynaud M; Turpin A; Bizzini B
    Prog Immunobiol Stand; 1967; 3():244-7. PubMed ID: 4985511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.